371 related articles for article (PubMed ID: 11716177)
1. Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis.
Steels E; Paesmans M; Berghmans T; Branle F; Lemaitre F; Mascaux C; Meert AP; Vallot F; Lafitte JJ; Sculier JP
Eur Respir J; 2001 Oct; 18(4):705-19. PubMed ID: 11716177
[TBL] [Abstract][Full Text] [Related]
2. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
Kawasaki M; Nakanishi Y; Kuwano K; Yatsunami J; Takayama K; Hara N
Clin Cancer Res; 1997 Jul; 3(7):1195-200. PubMed ID: 9815799
[TBL] [Abstract][Full Text] [Related]
3. The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis.
Meert AP; Martin B; Delmotte P; Berghmans T; Lafitte JJ; Mascaux C; Paesmans M; Steels E; Verdebout JM; Sculier JP
Eur Respir J; 2002 Oct; 20(4):975-81. PubMed ID: 12412692
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of p53 and bcl-2 abnormalities in operable nonsmall cell lung cancer.
Laudanski J; Niklinska W; Burzykowski T; Chyczewski L; Niklinski J
Eur Respir J; 2001 Apr; 17(4):660-6. PubMed ID: 11401061
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer.
Fujino M; Dosaka-Akita H; Harada M; Hiroumi H; Kinoshita I; Akie K; Kawakami Y
Cancer; 1995 Dec; 76(12):2457-63. PubMed ID: 8625071
[TBL] [Abstract][Full Text] [Related]
6. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
[TBL] [Abstract][Full Text] [Related]
7. CYP2E1 polymorphism, cigarette smoking, p53 expression, and survival in non-small cell lung cancer: a long term follow-up study.
Haque AK; Au W; Cajas-Salazar N; Khan S; Ginzel AW; Jones DV; Zwischenberger JB; Xie J
Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):315-22. PubMed ID: 15536330
[TBL] [Abstract][Full Text] [Related]
8. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis.
Zhan P; Wang J; Lv XJ; Wang Q; Qiu LX; Lin XQ; Yu LK; Song Y
J Thorac Oncol; 2009 Sep; 4(9):1094-103. PubMed ID: 19687765
[TBL] [Abstract][Full Text] [Related]
10. Prognostic prediction of the immunohistochemical expression of p53 and p16 in resected non-small cell lung cancer.
Cheng YL; Lee SC; Harn HJ; Chen CJ; Chang YC; Chen JC; Yu CP
Eur J Cardiothorac Surg; 2003 Feb; 23(2):221-8. PubMed ID: 12559346
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers.
Nishio M; Koshikawa T; Kuroishi T; Suyama M; Uchida K; Takagi Y; Washimi O; Sugiura T; Ariyoshi Y; Takahashi T; Ueda R; Takahashi T
J Clin Oncol; 1996 Feb; 14(2):497-502. PubMed ID: 8636763
[TBL] [Abstract][Full Text] [Related]
12. Expression of p16 in non-small cell lung cancer and its prognostic significance: a meta-analysis of published literatures.
Tong J; Sun X; Cheng H; Zhao D; Ma J; Zhen Q; Cao Y; Zhu H; Bai J
Lung Cancer; 2011 Nov; 74(2):155-63. PubMed ID: 21621871
[TBL] [Abstract][Full Text] [Related]
13. Serum anti-p53 antibodies in patients with lung cancer.
Mack U; Ukena D; Montenarh M; Sybrecht GW
Oncol Rep; 2000; 7(3):669-74. PubMed ID: 10767388
[TBL] [Abstract][Full Text] [Related]
14. Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor.
Lee JS; Yoon A; Kalapurakal SK; Ro JY; Lee JJ; Tu N; Hittelman WN; Hong WK
J Clin Oncol; 1995 Aug; 13(8):1893-903. PubMed ID: 7636531
[TBL] [Abstract][Full Text] [Related]
15. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.
Apolinario RM; van der Valk P; de Jong JS; Deville W; van Ark-Otte J; Dingemans AM; van Mourik JC; Postmus PE; Pinedo HM; Giaccone G
J Clin Oncol; 1997 Jun; 15(6):2456-66. PubMed ID: 9196162
[TBL] [Abstract][Full Text] [Related]
17. Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer.
Mitsudomi T; Oyama T; Kusano T; Osaki T; Nakanishi R; Shirakusa T
J Natl Cancer Inst; 1993 Dec; 85(24):2018-23. PubMed ID: 8246288
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: a systematic review with meta-analysis.
Meng D; Yuan M; Li X; Chen L; Yang J; Zhao X; Ma W; Xin J
Lung Cancer; 2013 Jul; 81(1):1-10. PubMed ID: 23608713
[TBL] [Abstract][Full Text] [Related]
19. Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis.
Martin B; Paesmans M; Berghmans T; Branle F; Ghisdal L; Mascaux C; Meert AP; Steels E; Vallot F; Verdebout JM; Lafitte JJ; Sculier JP
Br J Cancer; 2003 Jul; 89(1):55-64. PubMed ID: 12838300
[TBL] [Abstract][Full Text] [Related]
20. p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study.
Ahrendt SA; Hu Y; Buta M; McDermott MP; Benoit N; Yang SC; Wu L; Sidransky D
J Natl Cancer Inst; 2003 Jul; 95(13):961-70. PubMed ID: 12837832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
